Navigation Links
Vanderbilt scientists report first effective medical therapy for rare stomach disorder
Date:11/25/2009

A drug used to treat colorectal cancer also can reverse a rare stomach disorder and should be considered first-line therapy for the disease, researchers at Vanderbilt University Medical Center report this week.

Mntrier's disease causes thickening of the stomach lining, severe abdominal pain, nausea and vomiting, as well as anemia and swelling in the feet and ankles due to protein loss. Patients are at increased risk for gastric cancer. Previously, the only effective treatment was gastrectomy surgical removal of the stomach.

The targeted cancer drug cetuximab, brand name Erbitux, relieved symptoms of severe Mntrier's disease in seven patients who completed a one-month course of treatment. Four of them showed near-complete remission, the Vanderbilt researchers report in the Nov. 25 issue of the journal Science Translational Medicine.

"We have identified the first effective medical therapy for this disorder," said Robert Coffey, M.D., Ingram Professor of Cancer Research and the paper's senior author.

Erbitux is a monoclonal antibody that blocks the binding of transforming growth factor-alpha, or TGF-alpha, a signaling protein, to the epidermal growth factor (EGF) receptor. Patients with Mntrier's disease have abnormally high levels of TGF-alpha.

In studies dating back 20 years, Coffey and his colleagues found that TGF-alpha causes proliferation of the stomach lining and stimulates mucous production while suppressing acid secretion. Transgenic mice that over-express TGF-alpha in the stomach exhibit all of the hallmarks of Mntrier's disease.

The current study involved nine patients who were considering gastrectomy. Two patients dropped out of the study, but the rest experienced significant relief of symptoms within hours or days after beginning treatment. All seven continued taking the drug after the monthlong study ended.

Of the four patients who experienced near-complete remission of the disease, one of
'/>"/>

Contact: Bill Snyder
william.snyder@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Ovarian Cancer Coalition Partners With Consuelo Vanderbilt Costin
2. Vanderbilt Experts For Health Care Debate
3. Vanderbilt joins national consortium to develop new cancer therapies
4. Vanderbilt researchers pioneer an advanced sepsis detection and management system
5. NIH-funded Vanderbilt Research Seeks Ways to Avoid Information Overload in Health Care Choices Among Seniors
6. Vanderbilt University Medical Center and Waters Collaborate on Tissue Imaging Research Using SYNAPT HDMS
7. Vanderbilt Medical Center chosen as Evidence-based Practice Center
8. Vanderbilt nets brain gene research center
9. Childrens Hospital Oakland scientists discover soy component may be key to fighting colon cancer
10. BIDMC scientists awarded grants from Michael J. Fox Foundation for Parkinsons research
11. Scientists find molecular trigger that helps prevent aging and disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... Hiliary Critchley, Senior Manager for ... the 24th Annual WEDI National Conference ... Scottsdale, AZ. WEDI, the Workgroup for Electronic Data ... the use of health IT to create efficiencies ... of Telemedicine for UnitedHealthcare will co-present with Critchley ...
(Date:5/5/2015)... New York, New York (PRWEB) May 05, ... treatment lawsuits ( http://www.testosteronelawsuithub.com/ ) filed on ... cardiovascular complications due to their use of ... forward in the federal multidistrict litigation underway ... Illinois. According to court documents dated May ...
(Date:5/5/2015)... May 05, 2015 The newly minted Regan Arts ... of Dr. Brad Reedy from his 20 years working ... asked why she chose to publish a parenting book and why ... (and publisher) is the idea that it is a journey, not ... children are on the trek sometimes together and sometimes not...that each ...
(Date:5/5/2015)... May 05, 2015 Dr. Patricia George ... hypertension (PH). A pulmonologist and pulmonary hypertension specialist at ... attending a work event when an initial idea entered ... was sitting in the audience at the 2010 PHA ... of healthcare providers – were recalling their climb up ...
(Date:5/5/2015)... " QuickPick Travel ” was featured on ... a look small, medium, and large businesses making an impact ... a business expert, conducted the business review and shared with ... to three weeks of vacation for free. , Vacations are ... explore the world. And when people are preparing for vacations, ...
Breaking Medicine News(10 mins):Health News:Optimity Advisors’ Hiliary Critchley, Telemedicine Expert, to Speak at WEDI Conference May 20th in Scottsdale, AZ 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 4Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 2Health News:The Last Parenting Book You Will Ever Need: Veteran Publisher Judith Regan Releases A Provocative New Book By Dr. Brad Reedy, "The Journey Of The Heroic Parent" 3Health News:World PH Day: Team PHenomenal Hope Races to Spread the Word about Pulmonary Hypertension 2Health News:A Platform to Plan the Perfect Vacation was Featured on NewsWatch Television 2
... completing its review of safety,and efficacy data currently ... recommended that the pivotal Phase 3 clinical,trial FAME(TM) ... the current protocol, without change. The trial is ... of diabetic macular edema (DME). FAME is ...
... 17 "As a physician,you hear all sorts of ... Terry,D. Hashey, Medical Director of First Coast Family Medicine ... Campaign.,The most common that Dr. Hashey reports is the ... shot. "That couldn,t be farther from the truth.,The flu ...
... ImClone Systems,Incorporated (Nasdaq: IMCL ) and ... that they have established an agreement with Merck ... in,Japan. Under the terms of the agreement, ImClone ... a joint effort to develop and,following regulatory approval, ...
... - The numbers are staggering --,over 20% of people ... "It,s not the impairment or disability which creates dependency ... mainstream,social, economic and political opportunities," says Ron Nabors, Chief,Executive ... together to stand up and speak out on the,International ...
... Children in the South Bay,suffering from asthma, ... receive specialty care from Lucile Packard Children,s Hospital,physicians ... South Bay,Specialty Center in Los Gatos houses 13 ... hallmarks of its parent institution. "We,re very ...
... 16 AtriCure, Inc.,(Nasdaq: ATRC ), a ... products, today announced that results reporting on the ... to,treat atrial fibrillation (AF), were published in the ... an,electrophysiologist, and colleagues from the Oregon Heart and ...
Cached Medicine News:Health News:DSMB Supports Continuation of the Phase 3 Clinical Trial of Medidur(TM) FA for the Treatment of DME 2Health News:DSMB Supports Continuation of the Phase 3 Clinical Trial of Medidur(TM) FA for the Treatment of DME 3Health News:DSMB Supports Continuation of the Phase 3 Clinical Trial of Medidur(TM) FA for the Treatment of DME 4Health News:Flu Myths Abound in Flu Season 2Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 2Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 3Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 4Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 5Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 6Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 7Health News:CBM USA stands up and speaks out to world leaders on the International Day for the Eradication of Poverty 2Health News:Packard Children's Hospital Opens New South Bay Specialty Clinic Bringing Specialty Care Close to Home 2Health News:Published Results Using AtriCure Minimally Invasive Products 2Health News:Published Results Using AtriCure Minimally Invasive Products 3
(Date:5/5/2015)... JERUSALEM , May 5, 2015 ... ) ( http://www.oramed.com ), a clinical-stage pharmaceutical company ... systems, announced today that the company will present ... Oppenheimer 16th Annual Israeli Conference , ,Date: ... ,Presenter:       Nadav Kidron , Chief Executive Officer ...
(Date:5/5/2015)... China , May 5, 2015 Faced with ... rising public health awareness, China,s medical ... the markets with the largest demands have been ... Guangzhou and other first-tier cities. However, the entry ... short time makes these "high-end" markets in first-tier cities increasingly ...
(Date:5/5/2015)... , May 5, 2015  The Association of ... of Recognition™ to The Preoperative Stop and Go ... Ph.D. and Mauricio Gonzalez , M.D., anesthesia providers ... Preoperative Stop and Go Sign product is distributed by ... anesthesia management company, and is in compliance with the ...
Breaking Medicine Technology:Oramed to Present at Upcoming Conferences 2Oramed to Present at Upcoming Conferences 3MEDITEXPO JIANGSU 2015 is to Help Medical Device Companies Explore Business Opportunities in Wider Markets 2MEDITEXPO JIANGSU 2015 is to Help Medical Device Companies Explore Business Opportunities in Wider Markets 3MEDITEXPO JIANGSU 2015 is to Help Medical Device Companies Explore Business Opportunities in Wider Markets 4The Preoperative Stop and Go Sign Interactive Checklist Awarded AORN Seal of Recognition 2The Preoperative Stop and Go Sign Interactive Checklist Awarded AORN Seal of Recognition 3
... DDS Lab, a national dental laboratory based in Tampa, ... Available in over twenty-seven colors and designs with six ... of any athlete, from gymnasts to MMA fighters. According ... athlete is 60 times more likely to sustain damage ...
... ANGN ) today scheduled a conference call to discuss ... ended July 31, 2011. The call will be at 4:30 p.m. ... results for the third quarter of fiscal year 2011 after the ... wishing to participate can dial (877) 317-6789 or (412) 317-6789 to ...
Cached Medicine Technology:DDS Lab Launches Fierce™ Mouthguards 2Angeion Corporation to Report Third Quarter Fiscal Year 2011 Financial Results on Thursday, September 1, 2011 2
... Analyzer (PCA) is used in conjunction ... a variety of parameters in whole ... 50 patient records and permits on-screen ... as transmission of records to a ...
... images and patient information from all ... in one central system. It simplifies ... cost-effectiveness so that healthcare professionals can ... helping people., ,Many Sources, One Solution ...
... The Attain 4194 Bipolar over-the-wire left-heart lead ... This new steroid-eluting lead has an angled ... a guidewire or a stylet delivery method, ... maneuver and position the lead in a ...
... Our Maxenon Xi300 is so bright many ... have higher gears to shift into when the ... features such as a true Hot Start and ... 300-watt xenon system that prevent failed start ups ...
Medicine Products: